In summary, we identified a key oncogenic role of UCHL1 hypermethylation in NPC metastasis via the UCHL1/CTTN axis, which provides a novel therapeutic target for NPC treatment. This evidence concerns the gene CTTN and nasopharyngeal carcinoma.